Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development

Author： Becker Richard  

Publisher： Springer Publishing Company

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.23, Iss.2, 2007-04, pp. : 159-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacotherapy and Drug Development for Pulmonary Arterial Hypertension

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 180-188

Bentham Science Publishers

Access to resources Recommend Favorite

Thrombin Receptor: A Novel Target for Antiplatelet Drug Development

By Ray A.   Hegde L.G.   Gupta J.B.  

Thrombosis Research, Vol. 87, Iss. 1, 1997-07 ,pp. : 37-50

Elsevier

Access to resources Recommend Favorite

Assessing the Clinical Importance of Statistically Significant Improvement in Anti-Dementia Drug Trials

By  

Neuroepidemiology, Vol. 20, Iss. 2, 2001-05 ,pp. : 51-56

Karger

Access to resources Recommend Favorite

The role of clinical imaging in oncological drug development

By Murphy P S   McCarthy T J   Dzik-Jurasz A S K  

British Journal of Radiology, Vol. 81, Iss. 969, 2008-09 ,pp. : 685-692

British Institute of Radiology

Access to resources Recommend Favorite

Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease

By  

Current Vascular Pharmacology, Vol. 1, Iss. 3, 2003-10 ,pp. : 301-313

Bentham Science Publishers

Access to resources Recommend Favorite